Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Advaccine, Beigene, Biontech, Coherus, Cstone, Eli Lilly, Entos, Eqrx, Gloria, Harbour, Huya, Innocare, Inovio, Junshi, Ligand, Moderna, Neuren, Pfizer, Suzhou Genhouse.